Universal Biosensors, Inc. (ASX: $UBI) options issue overview

Universal Biosensors, Inc. (ASX: $UBI) has issued a target market determination (TMD) in relation to the offer to issue Options under a transaction specific prospectus dated Thursday, 11 April 2024. The TMD sets out the class of investors for which the Options would likely be consistent with their financial objectives, the distribution conditions, and restrictions imposed on the distribution of the Options.

Executive commentary on target market determination

This TMD has been produced to help investors understand who the offer of Options is most suitable for. It provides information on the target market, distribution conditions, review triggers, reporting requirements, and authorization. It is important for any recipient of this TMD to carefully read and consider the Prospectus in full and consult their stockbroker, accountant, solicitor, and/or other professional adviser if they have any questions regarding the contents of the Prospectus.

Summary of Universal Biosensors, Inc. (ASX: $UBI) options issue

Universal Biosensors, Inc. (ASX: $UBI) has issued a target market determination (TMD) in relation to the offer to issue Options under a transaction specific prospectus dated Thursday, 11 April 2024. The TMD outlines the class of investors for which the Options would likely be consistent with their financial objectives, the distribution conditions, and restrictions imposed on the distribution of the Options. It also details review triggers, reporting requirements, and authorization. The Options are being offered for a limited offer period set out in the Prospectus, after which the Options will no longer be available for investment. The TMD will only apply in the period between the commencement of the offer of the Options under the Prospectus and three months after the Closing Date of the Offer, after which the TMD will be withdrawn. The Issuer may also amend this TMD at any time.